Bedel Financial Consulting’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-35
Closed -$8K 328
2022
Q1
$8K Sell
35
-11
-24% -$2.58K ﹤0.01% 705
2021
Q4
$11K Buy
46
+34
+283% +$7.48K ﹤0.01% 669
2021
Q3
$2K Hold
12
﹤0.01% 872
2021
Q2
$3K Hold
12
﹤0.01% 822
2021
Q1
$2K Hold
12
﹤0.01% 838
2020
Q4
$2K Hold
12
﹤0.01% 736
2020
Q3
$2K Hold
12
﹤0.01% 700
2020
Q2
$2K Hold
12
﹤0.01% 676
2020
Q1
$2K Hold
12
﹤0.01% 663
2019
Q4
$2K Hold
12
﹤0.01% 671
2019
Q3
$3K Hold
12
﹤0.01% 606
2019
Q2
$2K Buy
+12
New +$2.21K ﹤0.01% 638
2018
Q3
Sell
-25
Closed -$4K 686
2018
Q2
$4K Hold
25
﹤0.01% 566
2018
Q1
$4K Buy
+25
New +$3.98K ﹤0.01% 566

Other funds holding CME

Bedel Financial Consulting's CME Position: Q2 2022 in Review

Bedel Financial Consulting sold out of CME Group (CME) in Q2 2022, closing a stake of 35 shares — an estimated $8K sold.

Bedel Financial Consulting first reported a position in CME in Q1 2018 and held it in 14 quarters. The position peaked at $11K in Q4 2021. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

  • Bedel Financial Consulting reported no remaining CME Group position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 35 CME Group shares in Q2 2022, an estimated $8K.
  • Bedel Financial Consulting first reported a position in CME Group in Q1 2018 and held it in 14 quarters.
  • Bedel Financial Consulting's CME Group position peaked at $11K in Q4 2021.
  • 1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.